Oxford covid antibody: No reactions seen as more volunteers get Covishield in India Kumar Jeetendra | August 28, 2020 Five volunteers were given Oxford covid-19 vaccine at Pune district Thursday as part of this phase II clinical trial. Three of these volunteers have been administered the Oxford COVID-19 vaccine candidate in Bharti Vidyapeeth’s Medical College and Hospital at Pune town while two more volunteers were inoculated with the Oxford COVID-19 vaccine candidate at the …
Russia delivers first group of Sputnik V for open: Report Kumar Jeetendra | September 8, 2020 Russia has released the first batch of COVID-19 vaccine, called Sputnik V, into civil movement and the supplies of the medication to the Russian regions are expected soon, said a report citing Russian Health Ministry. The Russian health ministry enrolled the first vaccine against COVID-19, developed by Gamaleya National Research Center of Epidemiology and Microbiology …
Bharat Biotech States Covaxin generated Strong immune response in monkeys Kumar Jeetendra | September 12, 2020 Bharat Biotech announced its prospective COVID-19 vaccine — Covaxin — was discovered to generate strong immune responses in rhesus macaques or monkeys, preventing infection and disease even upon high levels of exposure to live SARS-CoV-2 virus. The Hyderabad-based firm said data from the study on primates substantiate the immunogenicity of the vaccine candidate. Covaxin developed …
A few immunosuppressants don’t build COVID-19 risk: Scientists Kumar Jeetendra | September 15, 2020 Therapeutics which suppress the immune system in people who have inflammatory diseases like psoriasis and rheumatoid arthritis”are not associated with a significantly greater risk” for contracting COVID-19, according to a study which says these patients should continue taking their medicine as prescribed. Dermatology researchers in the Henry Ford Health System in the US, which treats …
Aurobindo Pharma ties up with BIRAC to create COVID-19 immunization Kumar Jeetendra | September 17, 2020 Aurobindo Pharma on Tuesday announced collaboration with the Biotechnology Industry Research Assistance Council (BIRAC), set up by the Department of Biotechnology for the development of COVID-19 vaccine. Aurobindo Pharma said it is developing a vaccine for COVID-19 through its wholly-owned US subsidiary, Auro Vaccines. “Aurobindo is in the process of preparing a state-of-art manufacturing facility …
Stage III preliminary of Oxford antibody to start in Pune one week from now Kumar Jeetendra | September 19, 2020 Pune, Sep 19 (PTI) The phase-III human clinical trial of the COVID-19 vaccine developed by Oxford University and being fabricated by the Serum Institute of India (SII) will begin at the Sassoon General Hospital in Pune next week. “The phase-III trial of”Covishield” vaccine will start in Sassoon hospital from next week. It’s likely to start …
Oxford Covid-19 immunization: Serum Institute starts phase 3 of clinical preliminary Kumar Jeetendra | September 21, 2020 The phase-III or the last stage of clinical trial of the Covid-19 vaccine’Covishield’, being developed by Oxford University, also fabricated by the Serum Institute of India (SII), began today at the state-run Sassoon General Hospital in Pune, Maharashtra on Monday, a senior official said. “We have begun the phase-III trials of the vaccine candidate. We’ll …
Flu antibody doesn’t expand COVID-19 danger: Study Kumar Jeetendra | September 22, 2020 Receiving the influenza vaccine does not increase a person’s risk for contracting COVID-19 or aggravate related conditions or mortality, according to a study. The study, published in the Journal of Clinical and Translational Science, shows the flu vaccine is the single most important intervention to help stay healthy. Seasonal flu activity is unpredictable, and healthy …
Bharat Biotech set to create intranasal COVID-19 immunization: Here is everything you require to know Kumar Jeetendra | September 23, 2020 Bharat Biotech Place to Create intranasal COVID-19 vaccine: This is all you need to know Hyderabad-based Bharat Biotech announced on September 23 that it has collaborated with the Washington University School of Medicine to develop an intranasal COVID-19 vaccine. Here are seven things you need to know about the novel chimp-adenovirus vaccine candidate: Bharat Biotech …
AstraZeneca gets halfway invulnerability in ease EU antibody bargain Kumar Jeetendra | September 25, 2020 European authorities will pay claims over an agreed limit against AstraZeneca over side-effects from its potential COVID-19 vaccine, under different terms to a deal struck with Sanofi, an EU official told Reuters. The deals reflect different approaches by two of the world’s best drugmakers for protecting themselves as a debate rages about liabilities for vaccines …
Johnson and Johnson’s COVID-19 immunization produces solid invulnerable reaction in early preliminary Kumar Jeetendra | September 26, 2020 Pharmaceutical giant Johnson & Johnson’s experimental COVID-19 vaccine has produced a strong immune response against the novel coronavirus in an early-to-mid stage clinical trial, in accordance with the data published on September 25. “The data demonstrate that a single dose of COVID-19 vaccine, Ad26.COV2.S, induced a powerful neutralising antibody response in nearly all participants aged …
Cat que infection: Another virus from China can possibly trigger general health emergency in India:ICMR Kumar Jeetendra | September 28, 2020 At a time when India is still grappling with the novel coronavirus pandemic that started in China’s Wuhan, scientists have warned of another virus from China that has the potential to spread diseases in India. Researchers at the Indian Council of Medical Research (ICMR) have discovered that the’cat que virus’ (CQV), that has infected many …
